Whole-exome sequencing and methylation profiling of serial CLL samples from eight patients before venetoclax treatment and at the time of venetoclax resistance did not show genetic alterations in BCL-2 (222). The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.